Healthcare / Medical Care FacilitiesHKSE
$26.90
-1.00 (-3.58%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $361.8M · quality 82.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.8B
P/E
16.0x
↓EV/EBITDA
10.1x
↓ROE
16.3%
↑Gross Margin
31.2%
↓Debt/Equity
0.36
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+26.0%
FCF CAGR
+26.6%
FCF margin
15.2%
FCF / Net income
1.40x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.25B · net income $352.8M · FCF $494.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.25B | $3.25B | $3.02B | $2.32B | $1.62B |
| Net Income | $352.8M | $352.8M | $306.8M | $252.2M | $180.9M |
| EBITDA | $637.5M | $637.5M | $531.9M | $429.9M | $324.2M |
| EPS | 1.45 | 1.45 | 1.22 | 1.03 | 0.76 |
| Gross Margin | 31.2% | 31.2% | 30.1% | 30.1% | 30.7% |
| Operating Margin | 14.2% | 14.2% | 12.1% | 12.0% | 12.5% |
| Net Margin | 10.9% | 10.9% | 10.2% | 10.9% | 11.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.36 | 0.36 | 0.21 | 0.16 | 0.20 |
| Current Ratio | 1.61 | 1.61 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $494.0M | $494.0M | $361.8M | $332.4M | $243.5M |
| Returns | |||||
| ROE | 16.3% | 16.3% | 12.9% | 10.9% | 10.5% |
| Valuation | |||||
| P/E | 16.01 | 16.01 | 25.45 | 45.58 | 62.43 |
| EV/EBITDA | 10.08 | 10.08 | 13.51 | 24.51 | 33.00 |
| P/B | 3.01 | 3.01 | 3.28 | 4.97 | 6.61 |
| Growth & Yield | |||||
| Revenue Growth | 7.5% | 7.5% | 30.1% | 43.0% | — |
| EPS Growth | 18.9% | 18.9% | 18.4% | 35.5% | — |
| Dividend Yield | 3.9% | 3.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
18.1%
EPS terminal req.
$2.39
Spread vs growth
0.8%
5Y implied EPS CAGR
14.8%
EPS terminal req.
$2.89
Spread vs growth
4.1%
10Y implied EPS CAGR
12.4%
EPS terminal req.
$4.65
Spread vs growth
6.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-18.0%
Start / end P/E
28.2x → 18.6x
EPS bridge
1.22 → 1.45
Residual
-6.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.